Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Jong Ran Kim"'
Publikováno v:
Journal of Clinical Oncology. 40:7522-7522
7522 Background: Anbal-cel is a novel 2nd generation autologous CD19 CAR-T cell therapy which has been knock-downed for PD-1 and TIGIT using OVIS platform. Anbal-cel demonstrated the eradication of CD19 positive tumor cells in vitro and in vivo bette
Autor:
Jong Ran Kim
Publikováno v:
The Korean Society of Beauty and Art. 18:239-251
Publikováno v:
Heartlung : the journal of critical care. 46(3)
Objectives To identify factors associated with mortality in patients treated with veno-arterial extracorporeal membrane oxygenation (VA-ECMO) and to validate the discrimination of the risk assessment tools to predict mortality. Background VA-ECMO is
Autor:
Won-Ha Lee, Sung S Rhee, Sung-Youn Lee, Jong-Ran Kim, Joon-Soo Kim, Jung-Don Seo, Yoon Lee, Jeong-Euy Park, Jin-A Chu, Jin-Ok Jung, Seonwoo Kim
Publikováno v:
Experimental & Molecular Medicine. 31:159-164
Inflammation and activation of immune cells have important roles in the pathogenesis of atherosclerosis. We analyzed the plasma levels of inflammatory markers and the degree of activation of peripheral blood monocytes and T-lymphocytes isolated from
Autor:
Jeong Euy Park, Kyung Pyo Hong, Seung Woo Park, Sung Youn Lee, Won Ha Lee, Yoon Kyung Lee, Jung Don Seo, Hyeon Cheol Gwon, Jong Ran Kim, Sang-Hoon Lee, Won Ro Lee, Jin Ok Jung, June Soo Kim, Duk Kyung Kim
Publikováno v:
Korean Circulation Journal. 30:56
Background and Objectives:Inflammation and activation of immune cells play important roles in the pathogenesis of atherosclerosis. We investigated the activation status of plasma inflammatory markers and immune cells in angina patients. Methods:We an